Phase 1 study

Recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 1
Sponsor Feldan Therapeutics
Registry number NCT07670858
Started 30 October 2024 Today 16 October 2026 Estimated completion 1 February 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Woden Dermatology Phillip ACT Recruiting
Novatrials Charlestown NSW Recruiting
Scientia Clinical Research Randwick NSW Recruiting
Innovate Clinical Research Waitara NSW Recruiting
FNQH Cairns Skin Cancer Clinic Westcourt QLD Recruiting
Translational Research Institute Woolloongabba QLD Recruiting
Veracity Clinical Research Woolloongabba QLD Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 85 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 48

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* You are between 18 and 85 years old.

* You are willing to attend all study visits and follow the study procedures.

* You have been diagnosed with at least one nodular basal cell carcinoma (a type of skin cancer) that has never been treated and suitable for treatment and final excision by the Investigator.

* You are willing to avoid certain medications during the study as instructed by the study doctor.

* You are not currently participating in another clinical study.

* If you are a woman who could become pregnant, you must:

* Have a negative pregnancy test at the start of the study.

* Use effective birth control during the study and for 90 days after your last dose.

* Not breastfeed during the study and for 90 days after your last dose.

* If you are a man, you must use a condom during the study and for 90 days after your last dose if you have sex with a partner who could become pregnant.

Exclusion Criteria:

* You are currently breastfeeding.

* You have a known allergy or sensitivity to any ingredient in the study drug or to red tattoo ink.

* Your skin lesion is located in a high-risk area, such as near the eyes, nose, ears, lips, scalp, or on the hands or fingers.

* Your skin lesion needs to be removed urgently.

* Your basal cell carcinoma has spread to other parts of the body.

* You have received radiation therapy directly on or near the skin lesion being treated in this study.

* You have received phototherapy (such as Ultraviolet A or B light therapy) in the past 4 weeks or are expected to receive it during the study.

* You have been diagnosed with a liver or kidney disease that the study doctor considers significant.

* You are immunocompromised or have an active infection such as Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C or active Tuberculosis.

* You have or had another cancer in the past 5 years

* You have a skin condition associated with an increased risk of developing skin cancers (such as Xeroderma Pigmentosum).

* You have uncontrolled high blood pressure or a heart rhythm problem.

* You have had significant alcohol or drug use issues in the past 6 months, or have a mental health condition that the study doctor believes may affect your ability to participate safely.

* You are currently taking certain medications that are not allowed during the study

* You are an employee or family member of an employee at the study site or of the study doctor.

Dates on the record

Started 30 October 2024
Estimated completion 1 February 2027
Registry last updated 29 June 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 29 June 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.